UnitedHealth Group Incorporated (NYSE:UNH) is Rockland Trust Co.’s 9th largest holding.

VaselineOctober 5, 2024

0 5 minutes read

Rockland Trust Co. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.2% during the third quarter, Holdings Channel reports. The fund owned 77,981 shares of the health care conglomerate’s stock after selling 119 shares during the quarter. UnitedHealth Group makes up about 2.2% of Rockland Trust Co.’s investment portfolio, making the stock its 9th biggest holding. Rockland Trust Co. holdings. holdings in UnitedHealth Group were worth $45,594,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of UNH. CFS Investment Advisory Services LLC boosted its holdings in shares of UnitedHealth Group by 55.0% during the 4th quarter. CFS Investment Advisory Services LLC now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,453,000 after bought an additional 979 shares in the last quarter. CenterBook Partners LP raised its position in UnitedHealth Group by 69.6% during the 4th quarter. CenterBook Partners LP now owns 11,749 shares of the healthcare conglomerate’s stock worth $6,185,000 after buying an additional 4,821 shares during the period. shares in the last quarter. AdvisorShares Investments LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $416,000. Delaney Dennis R boosted its position in UnitedHealth Group by 13.0% in the fourth quarter. Delaney Dennis R now owns 8,051 shares of the healthcare conglomerate’s stock worth $4,239,000 after buying an additional 925 shares during the period. Finally, Broderick Brian C raised its position in UnitedHealth Group by 4.0% in the fourth quarter. Broderick Brian C now owns 18,607 shares of the healthcare conglomerate’s stock valued at $9,796,000 after buying an additional 713 shares during the period. 87.86% of the shares are currently owned by institutional investors and hedge funds.

Insider buying and selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC’s website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a filing with the SEC, which is accessible via this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of shares are owned by corporate insiders.

UnitedHealth Group trading rose 0.1%

Want more great investment ideas?

NYSE:UNH opened at $592.75 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88, and a quick ratio of 0.88. The firm has a market cap of $547.36 billion, a P/E ratio of 36.23, a P/E/G ratio of 1.62 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a 50-day simple moving average of $581.82 and a 200-day simple moving average of $526.64.

UnitedHealth Group (NYSE:UNH – Get Your Free Report ) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue increased by 6.4% year-on-year. In the same period last year, the company posted earnings of $6.14 per share. equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a dividend of $8.40 on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street analysts weigh in

UNH has been the subject of several analyst reports. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the stock from $481.00 to $647.00 in a report on Wednesday. , July 17. Barclays boosted their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 25th. Truist Financial raised their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th . Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $614.17, according to MarketBeat .

Get the latest research report on UnitedHealth Group

UnitedHealth Group Profile

(Free report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.